- Home
- SOFI vs PCVX Comparison
SOFI vs PCVX Comparison
Compare SOFI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOFI
- PCVX
- Stock Information
- Founded
- SOFI 2011
- PCVX 2013
- Country
- SOFI United States
- PCVX United States
- Employees
- SOFI N/A
- PCVX N/A
- Industry
- SOFI Diversified Financial Services
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- SOFI Finance
- PCVX Health Care
- Exchange
- SOFI Nasdaq
- PCVX Nasdaq
- Market Cap
- SOFI 11.7B
- PCVX 14.7B
- IPO Year
- SOFI N/A
- PCVX 2020
- Fundamental
- Price
- SOFI $11.37
- PCVX $106.97
- Analyst Decision
- SOFI Buy
- PCVX Strong Buy
- Analyst Count
- SOFI 14
- PCVX 7
- Target Price
- SOFI $9.00
- PCVX $147.50
- AVG Volume (30 Days)
- SOFI 57.0M
- PCVX 636.4K
- Earning Date
- SOFI 10-29-2024
- PCVX 11-04-2024
- Dividend Yield
- SOFI N/A
- PCVX N/A
- EPS Growth
- SOFI N/A
- PCVX N/A
- EPS
- SOFI 0.12
- PCVX N/A
- Revenue
- SOFI $2,501,193,000.00
- PCVX N/A
- Revenue This Year
- SOFI N/A
- PCVX N/A
- Revenue Next Year
- SOFI $14.93
- PCVX N/A
- P/E Ratio
- SOFI $90.30
- PCVX N/A
- Revenue Growth
- SOFI 31.21
- PCVX N/A
- 52 Week Low
- SOFI $6.01
- PCVX $46.16
- 52 Week High
- SOFI $11.34
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- SOFI 68.85
- PCVX 39.76
- Support Level
- SOFI $9.77
- PCVX $102.84
- Resistance Level
- SOFI $11.34
- PCVX $115.56
- Average True Range (ATR)
- SOFI 0.48
- PCVX 3.32
- MACD
- SOFI 0.05
- PCVX -1.41
- Stochastic Oscillator
- SOFI 84.87
- PCVX 21.55
About SOFI SoFi Technologies Inc.
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.